The peer-reviewed study, entitled “US Cannabis Laws Projected To Cost Generic And Brand Pharmaceutical Firms Billions”, analyzed how publicly traded pharmaceutical firms fared after adult-use or medical marijuana laws were enacted by states. According to Ziemowit Bednarek, California Polytechnic State University’s Finance Department, together with Sarah Stith, pharmaceutical stocks were worth 1.5-2% lower in only 10 days following cannabis legalization.
Ladies and gentlemen, we have a new contender for the most audacious cannabis caper of…
How much should an ounce of weed cost? As the U.S. cannabis market surges past…
Find the best high-potency hemp products of 2025. Leafly reviewed popular hemp products & chose…
A breakdown of the situation regarding hemp, cannabis, and THCA—courtesy of The Hemp Doctor. The…
Well, folks, it looks like Donald Trump might be the best thing to happen to…
In a policy memo that reeks of entitlement, the American Beverage Licensees (ABL) trade association…
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
